Edition:
India

Harbin Pharmaceutical Group Co Ltd (600664.SS)

600664.SS on Shanghai Stock Exchange

4.17CNY
8:59am IST
Change (% chg)

¥-0.01 (-0.24%)
Prev Close
¥4.18
Open
¥4.10
Day's High
¥4.22
Day's Low
¥4.01
Volume
32,575,454
Avg. Vol
30,177,304
52-wk High
¥6.80
52-wk Low
¥3.27

Latest Key Developments (Source: Significant Developments)

Owner Of Harbin Pharma's Controlling Shareholder Set To Change To Citic Capital
Friday, 23 Feb 2018 

Feb 23 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS CONTROLLING SHAREHOLDER'S OWNER SET TO CHANGE TO CITIC CAPITAL FROM HARBIN STATE ASSET REGULATOR AFTER CAPITAL BOOST.SAYS CITIC CAPITAL WILL OWN 60.9 PERCENT STAKE IN ITS CONTROLLING SHAREHOLDER, HARBIN STATE ASSET REGULATOR'S STAKE WILL BE REDUCED TO 32.0 PERCENT.  Full Article

Harbin Pharma Scraps Plan For Unit To Bid For GNC's China Business
Wednesday, 14 Feb 2018 

Feb 14 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS CONTROLLING SHAREHOLDER SIGNS AGREEMENT TO BUY GNC HOLDINGS' <<>> CONVERTIBLE PREFERENCE SHARES WORTH $299.95 MILLION.SAYS IT SCRAPS PLAN FOR UNIT HPGC RENMINTONGTAI PHARMA TO BID GNC'S CHINA BUSINESS.  Full Article

GNC And Harbin Pharmaceutical Announce $300 Mln Strategic Investment
Tuesday, 13 Feb 2018 

Feb 13 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::GNC AND HARBIN PHARMACEUTICAL ANNOUNCE $300 MILLION STRATEGIC INVESTMENT AND CHINA JOINT VENTURE.GNC HOLDINGS INC - ‍ALSO ANNOUNCED PLANS TO AMEND CERTAIN TERMS AND EXTEND MATURITY DATE OF ITS EXISTING TERM LOAN FACILITY DUE MARCH 2019​.GNC HOLDINGS INC - ‍COMPANY IS SEEKING TO EXTEND MATURITY DATE OF FACILITY BY TWO YEARS, TO MARCH 2021​.GNC HOLDINGS INC - ‍UPON EFFECTIVENESS OF AMENDMENT, MATURITY DATE OF TERM LOANS HELD BY LENDERS CONSENTING TO AMENDMENT WILL BE EXTENDED BY TWO YEARS​.GNC HOLDINGS -‍UPON EFFECTIVENESS OF AMENDMENT, CO'S EXISTING REVOLVING CREDIT FACILITY WILL BE CANCELLED, GNC WILL ENTER INTO NEW $100 MILLION ABL REVOLVER​.GNC HOLDINGS INC - ‍COMPANY WILL ALSO ISSUE A $275 MILLION ABL TERM LOAN AS PART OF MATURITY EXTENSION​.GNC HOLDINGS- REACHED AGREEMENT REGARDING STRATEGIC PARTNERSHIP AND CHINA JOINT VENTURE AGREEMENT WITH HARBIN PHARMACEUTICAL GROUP HOLDING CO., LTD​.GNC HOLDINGS INC - ‍UNDER TERMS OF AGREEMENT HAYAO WILL INVEST APPROXIMATELY $300 MILLION IN GNC, BECOMING SINGLE LARGEST SHAREHOLDER IN GNC​.GNC HOLDINGS - ‍IN CONNECTION WITH INVESTMENT, GNC BOARD TO BE EXPANDED TO 11 MEMBERS INCLUDING 5 MEMBERS FROM GNC, 5 MEMBERS FROM HAYAO,KEN MARTINDALE​.GNC HOLDINGS - ‍IN ADDITION, GNC,HAYAO HAVE AGREED TO FORM JOINT VENTURE FOR MANUFACTURING, MARKETING, SALE, DISTRIBUTION OF GNC-BRANDED PRODUCTS IN CHINA​.  Full Article

Harbin Pharmaceutical's 2017 Net Profit Down 48.4 Percent Y/Y At 407.0 Million Yuan
Friday, 9 Feb 2018 

Feb 9 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS 2017 NET PROFIT DOWN 48.4 PERCENT Y/Y AT 407.0 MILLION YUAN ($64.64 million).  Full Article

Harbin Pharmaceutical Expects 2017 Net Profit To Fall 46-51 Percent Y/Y
Tuesday, 30 Jan 2018 

Jan 30 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS IT EXPECTS 2017 NET PROFIT TO FALL 46-51 PERCENT Y/Y VERSUS 788.1 MILLION YUAN ($124.40 million) YEAR AGO.  Full Article

Harbin Pharmaceutical's 9-month net profit down 56.8 pct y/y
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>:Says 9-month net profit down 56.8 percent y/y.  Full Article